Stock MDAI SPECTRAL AI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Spectral AI, Inc.

Equities

MDAI

US84757T1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
1.99 USD +3.65% Intraday chart for Spectral AI, Inc. +2.05% -19.11%
03:39pm Spectral AI Partners With PolyNovo to Deploy Burn Wound Diagnostics System in Australia MT
02:00pm Spectral AI, Inc. Announces Collaboration with PolyNovo Limited CI

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 87% by 2026.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
SPECTRAL AI, INC. Stock Spectral AI, Inc.
-19.11% 33.57M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-5.00% 29.66B
C
SECTRA AB Stock Sectra AB
+33.14% 4.4B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-40.72% 2.29B
C-
VERADIGM INC. Stock Veradigm Inc.
-8.01% 1.6B -
C+
OMNICELL, INC. Stock Omnicell, Inc.
-30.14% 1.22B
B
LUNIT INC. Stock Lunit Inc.
-41.70% 970M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-10.93% 778M
C
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-50.99% 718M -
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-31.40% 626M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MDAI Stock
  4. Ratings Spectral AI, Inc.